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SUMMARY
Clinical strains of Enterobacter were isolated from Cumana’s Central Hospital in Venezuela, and classified as E. cloacae (21), E. 
aerogenes (7), E. intermedium (1), E. sakazakii (1) and three unclassified. The strains showed high levels of resistance, especially to 
SXT (58.1%), CRO (48.8%), CAZ (46.6%), PIP (46.4%), CIP (45.2%) and ATM (43.3%). This is the first report for South America of 
blaVIM-2 in two E. cloacae and one Enterobacter sp., which also showed multiple mechanisms of resistance. Both E. cloacae showed 
blaTEM-1, but only one showed blaCTX-M-15 gene, while no blaSHV was detected.
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INTRODUCTION
Species of the genus Enterobacter have been reported as an important 
source of intrahospital infections, especially those showing resistance to 
betalactams by the production of enzymes like extended spectrum beta-
lactamases (ESBL) such as TEM, SHV, CTX, VEB, and carbapenemases 
such as VIM, KPC and GES14. This represents an important therapeutic 
challenge because of the few remaining treatment options, which gives 
rise to morbimortality and hospital expenses.
There are reports of Enterobacter strains producing metallo-β-
lactamase (MBL) in different parts of the world, such as E. cloacae in 
Japan, Taiwan, Korea and Italy, as well as E. aerogenes in Japan and 
France2. However, no MBL-producing strains of Enterobacter have been 
reported anywhere in the Americas, except in Mexico11 and Argentina4.
METHODS
During August 2010 and March 2011, clinical strains of Enterobacter 
were isolated in the University Hospital Antonio Patricio de Alcala in 
Cumana, Venezuela. The use of the strains was approved by the patients 
or their relatives, according to the recommendations of the Bioethics 
and Biosecurity Committee of IIBCA, Universidad de Oriente, Cumana, 
Venezuela.
Isolated strains were inoculated in BHI broth, incubated for 12 hours 
at 37 ºC and later in MacConkey agar for 24 hours, in order to evaluate 
the morphological characteristics of the colonies to verify purity. For the 
classification of Enterobacter species tests for the fermentation of glucose 
and lactose in Kligler medium, use of citrate, arginine and malonate, use 
of MIO, LIA, and methyl red and Voges-Proskauer medium according 
to standard biochemical tests established for Enterobacteriaceae8,16.
Antimicrobial susceptibility was assessed by Kirby-Bauer disk 
diffusion susceptibility test following the recommendations of the 
Clinical and Laboratory Standards Institute (CLSI). For tigecycline 
(TGC), we used the cutoff of the attached insert (Pfizer, INC). 
Screening of extended spectrum beta-lactamases (ESBL), were 
carried out using the synergy effect between the antimicrobial disks 
CAZ, FEP, CRO, ATM and CTX surrounding AMC as well as the 
confirmatory test for ESBL was carried out using the combined disc test7. 
Additionally, in order to detect the presence of ESBL enzymes we used 
the modification suggested by SONG et al. (2007), in order to avoid the 
masking effect that a derepressed AmpC gene could produce15. For this, 
disks containing CAZ (30 μg) with and without clavulanic acid (10 μg) 
were added 3-aminophenyl boronic acid with a final amount of 400 μg.
The phenotypic detection of MBLs was carried out using IPM 
and MER disks on each side of a disk with ethylendiaminotetracetic 
acid-sodium mercaptoacetate (EDTA-SMA, 0.5 μmoles-3 μg) and the 
combined disc test (IMP, IMP-EDTA and MER, MER-EDTA)6.
DNA extraction was carried out using the Wizard Genomic DNA 
kit (Promega) from the strains isolated after incubation in LB broth 
for 20 hours at 37 ºC. The blaVIM gene was detected by PCR according 
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to MENDEZ et al.10. Additionally, we detected the type 1 and 2 blaVIM 
according to FIETT et al.3. The genes blaCTX-M (EDELSTEIN et al. 
unpublished results, http://www.antibiotic.ru/en/pdfs/006-51.pdf), blaTEM 
and blaSHV12 were also detected. Finally, in order to determine the clonality 
of the three Enterobacter strains showing a phenotype consistent with 
MBL by the IMP/MER/EDTA synergy test, we used ERIC-PCR13.
RESULTS
The 33 strains of Enterobacter isolated were classified as E. cloacae 
(21), E. aerogenes (7), E. intermedium (1), E. sakazakii (1) and three 
were not possible to classify.
Ten of the strains were from infections acquired outside the hospital 
and most of the intrahospitalary strains were isolated in ICU (5), internal 
medicine areas A and B (4), soft surgery hall (4), pediatric area (3) and 
neonatology (3).
Antimicrobial susceptibility tests show high levels of resistance 
in most of the strains, with resistance to SXT (58.1%), CRO (48.8%), 
CAZ (46.6%), PIP (46.4%), CIP (45.2%) and ATM (43.3%) being the 
highest (Fig. 1). However, all the strains were sensitive to TGC. Results 
of the synergy test between CAZ/FEP/CRO/CTX/ATM with AMC in 
16 of the strains were compatible with ESBL enzymes. We found that 
these strains showed the typical phenotypic effect for ESBL enzymes 
when using the combined disc test as a confirmatory. Additionally, three 
of the Enterobacter strains (two E. cloacae and one Enterobacter sp.) 
were resistant to cabapenems showing also synergy between IPM/MER 
and EDTA, typical of MBL enzymes (Table 1). ERIC-PCR patterns 
show no similarities among these strains. They showed resistance to 
multiple families of antibiotics (MDRs) and two of them also showed 
presence of ESBL by the synergy assay. These strains amplified for 
blaVIM-2 fragments (801 bp). Furthermore, both strains of E. cloacae 
amplified the typical fragment of the blaTEM gene (1080 bp), but only 
one of them amplified the fragment of the blaCTX-M gene (543 bp), while 
no blaSHV gene was detected.
Sequencing of the fragment of the blaVIM gene, amplified using 
primers for type 2, produced sequences 100% homologous to blaVIM-2 
reported in the GenBank in P. aeruginosa and other bacteria. Also, the 
sequences of the blaTEM gene were 100% homologous to type 1 reported 
for many Enterobacteria. In addition, the fragment of the blaCTX-M gene 
sequenced showed 100% homology with CTX-M-15 found in E. coli 
and other Enterobacteria.
DISCUSSION
According to our phenotypic tests, BLEA and ESBL-type of 
enzymes was very prevalent. On the other hand, we are not aware 
of previous reports of the presence of VIM-producing Enterobacter 
strain in any South American country. In Mexico, strains of E. cloacae 
Table 1
Resistance pattern and epidemiological data of the three strains of Enterobacter showing blaVIM type 2 MBLs
Species Isolation date Hospital area Type of sample Resistance pattern Synergy tests Detected genes
E. cloacae August 2010 Soft Surgery catheter CAZ, FEP, IPM, 
MER, TZP, PIP, 







Enterobacter sp. March 2011 ICU bronchial 
secretion
CAZ, FEP, IPM, 
MER, TZP, PIP, 





E. cloacae April 2011 Internal 
Medicine B
urine CAZ, FEP, IPM, 
MER, TZP, PIP, 






ESBL: extended-spectrum betalactamase, MBL: metallo-β-lactamase, AmpC: de-repression of the chromosomal AmpC gene. ICU: intensive care unit. Acronyms of 
antibiotic as shown in the legend of Fig. 1.
Fig. 1 - Antimicrobial susceptibility of the Enterobacter strains isolated in the Cumana 
hospital of Venezuela. CAZ: ceftazidime, CRO: ceftriaxone, FEP: cefepime, ATM: aztreonam, 
IPM: imipenem, MER: meropenem, PIP: piperacillin, TZP: piperacillin/tazobactam, SXT: 
trimethoprim-sulfamethoxazole, GM: gentamicin, AK: amikacin, CIP: ciprofloxacin and 
TGC: tigecycline.
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have been shown to produce MBL11. These strains produced blaVIM-2 
MBLs, the same type we found in this study. In Argentina, one strain 
of E. cloacae was reported containing blaIMP gene, along with blaPER 
and genes that confer resistance to aminoglycosides and quinolones4. 
This type of gene has been reported in Venezuela but only in strains 
of Pseudomonas aeruginosa and Klebsiella pneumoniae5,9. VIM-
producing P. aeruginosa strains were previously found in Cumana 
hospital (ENSONY TOVAR & MARCOS DE DONATO, unpublished 
results). It seems very likely that the gene found in P. aeruginosa could 
have been transferred through mobile elements such as plasmid and/
or integrons between these two species which are sharing the same 
environment, as previously reported14, making possible the spread 
of this gene to many other bacteria species causing infection in this 
hospital environment.
The presence of multiple mechanisms of resistance in the bacteria 
isolated in the Cumana hospital causing intrahospital infections, 
especially in species of Enterobacter, which have natural resistance 
to several antibacterial drugs, suggests that more efficient preventive 
measures must be put in place in this hospital to avoid the survival and 
transmission of these strains. However, all the strains were susceptible 
to tigecycline, making it a suitable treatment for infections caused 
by MBL-producing enzymes in this hospital. This result agrees with 
numerous reports describing the use of tigecycline to treat infections 
caused by multidrug resistant bacteria, including those producing 
carbapenemases14.
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RESUMEN
Primer reporte de cepas de Enterobacter spp productoras de 
metalobetalactamasas de Venezuela
Cepas clínicas de Enterobacter fueron aisladas del Hospital central 
de Cumaná en Venezuela, y se clasificaron como E. cloacae (21), E. 
aerogenes (7), E. intermedium (1), E. sakazakii (1) y 3 sin clasificar. 
Las cepas mostraron altos niveles de resistencia, especialmente a SXT 
(58.1%), CRO (48.8%), CAZ (46.6%), PIP (46.4%), CIP (45.2%) and 
ATM (43.3%). Este es el primer reporte de América del Sur de blaVIM-2 
en dos cepas de E. cloacae y una de Enterobacter sp., las cuales también 
mostraron múltiples mecanismos de resistencia. Ambas especies de E. 
cloacae mostraron genes blaTEM-1, pero solo una mostro el gen blaCTX-M-15, 
mientras que blaSHV no fue detectado.
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